Ahn-Gook Pharmaceutical Co. Ltd (001540) — Cash Flow Reinvestment Rate
Ahn-Gook Pharmaceutical Co. Ltd (001540) has a Cash Flow Reinvestment Rate of 0.22x as of September 2025, reinvesting ₩3.11 Billion (capex ₩2.76 Billion plus investments ₩-351.36 Million) from operating cash flow of ₩14.44 Billion. Explore Ahn-Gook Pharmaceutical Co. Ltd (001540) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ahn-Gook Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2012–2024)
Historical reinvestment intensity for Ahn-Gook Pharmaceutical Co. Ltd across 11 annual periods. Also explore 001540 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Ahn-Gook Pharmaceutical Co. Ltd (2012–2024)
Year-by-year capital reinvestment analysis for Ahn-Gook Pharmaceutical Co. Ltd. For live market cap and broader valuation context, see 001540 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 30.78x | ₩151.27 Billion | ₩4.91 Billion | ₩75.89 Billion | ▲ +327.1% |
| 2022 | 7.21x | ₩12.89 Billion | ₩1.79 Billion | ₩2.93 Billion | ▲ +18.4% |
| 2021 | 6.09x | ₩8.97 Billion | ₩1.47 Billion | ₩4.04 Billion | ▲ +74.1% |
| 2020 | 3.50x | ₩39.14 Billion | ₩11.19 Billion | ₩24.12 Billion | ▲ +191.1% |
| 2019 | 1.20x | ₩26.53 Billion | ₩22.08 Billion | ₩3.74 Billion | ▲ +146.3% |
| 2017 | 0.49x | ₩8.52 Billion | ₩17.46 Billion | ₩4.79 Billion | ▼ -21.9% |
| 2016 | 0.62x | ₩7.89 Billion | ₩12.62 Billion | ₩4.38 Billion | ▼ -26.7% |
| 2015 | 0.85x | ₩16.28 Billion | ₩19.11 Billion | ₩2.33 Billion | ▼ -92.2% |
| 2014 | 10.99x | ₩14.14 Billion | ₩1.29 Billion | ₩7.16 Billion | ▲ +507.0% |
| 2013 | 1.81x | ₩6.60 Billion | ₩3.64 Billion | ₩6.60 Billion | ▲ +708.3% |
| 2012 | 0.22x | ₩2.58 Billion | ₩11.51 Billion | ₩2.58 Billion | — |